Ignite Creation Date:
2025-12-24 @ 10:54 PM
Ignite Modification Date:
2025-12-31 @ 8:03 AM
Study NCT ID:
NCT04520269
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-09-25
First Post:
2020-08-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Single Arm, Phase Ib/II Trial of Single Agent Pacritinib in Patients With 1q21.3 Amplified Solid Tumors Enriching for Interleukin-1 Receptor-associated Kinase 1 Pathway Activation (PAIR)
Sponsor:
National University Hospital, Singapore
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-07-13
Start Date Type:
ACTUAL
Primary Completion Date:
2026-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-07
Completion Date Type:
ESTIMATED
First Submit Date:
2020-08-11
First Submit QC Date:
None
Study First Post Date:
2020-08-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-22
Last Update Post Date:
2025-09-25
Last Update Post Date Type:
ESTIMATED